Core Laboratories Inc
F:HJ1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (15.8), the stock would be worth €0.6 (96% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 382.9 | €14.6 |
0%
|
| Industry Average | 15.8 | €0.6 |
-96%
|
| Country Average | 21.9 | €0.83 |
-94%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| US |
C
|
Core Laboratories Inc
F:HJ1
|
673m EUR | 382.9 | 26.1 | |
| US |
|
Schlumberger NV
NYSE:SLB
|
85.1B USD | 31.2 | 25.5 | |
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
69.1B USD | 34.1 | 22.2 | |
| US |
|
Halliburton Co
NYSE:HAL
|
35.3B USD | 21.1 | 22.9 | |
| LU |
|
Tenaris SA
MIL:TEN
|
27.6B EUR | 18.3 | 16.9 | |
| UK |
|
TechnipFMC PLC
NYSE:FTI
|
30.3B USD | 33.6 | 31.4 | |
| CN |
|
Yantai Jereh Oilfield Services Group Co Ltd
SZSE:002353
|
140.3B CNY | 74.5 | 50 | |
| UK |
|
Subsea 7 SA
OSE:SUBC
|
98.7B NOK | 14.3 | 25.4 | |
| IT |
|
Saipem SpA
MIL:SPM
|
8.9B EUR | 42.5 | 18.8 | |
| FR |
|
Technip Energies NV
PAR:TE
|
7.1B EUR | 14.4 | 19.4 | |
| US |
|
Weatherford International PLC
NASDAQ:WFRD
|
7.9B USD | 38.8 | 17.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.1 |
| Median | 21.9 |
| 70th Percentile | 36.5 |
| Max | 3 188 432.5 |
Other Multiples
Core Laboratories Inc
Glance View
Core Laboratories, Inc. provides proprietary and patented reservoir description and production enhancement services. The company is headquartered in Houston, Texas and currently employs 3,600 full-time employees. The company went IPO on 2018-10-22. The firm provides services to oil companies. Its reservoir optimization technologies are used to enhance total recovery from existing fields. Its services enable its clients to optimize reservoir performance and maximize hydrocarbon recovery from their producing fields. Its Reservoir Description segment provides laboratory-based analytical and field services to characterize properties of crude oil and crude oil-derived products to the oil and gas industry. In addition, it provides reservoir description capabilities that support various activities associated with energy transition projects, including services that support carbon capture, utilization and storage, hydrogen storage, and geothermal projects. Its Production Enhancement segment includes services and manufactured products associated with reservoir well completions, perforations, stimulation, production and well abandonment.
